GLMD vs. PHIO
GLMD (Galmed Pharmaceuticals Ltd.) and PHIO (Phio Pharmaceuticals Corp.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, GLMD returned -50.77%/yr vs -69.29%/yr for PHIO. Their 0.16 correlation means their historical movements had little consistent relationship.
Performance
GLMD vs. PHIO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GLMD achieves a -17.26% return, which is significantly lower than PHIO's -2.38% return. Over the past 10 years, GLMD has outperformed PHIO with an annualized return of -50.77%, while PHIO has yielded a comparatively lower -69.29% annualized return.
GLMD
- 1D
- 3.67%
- 1M
- 8.87%
- 6M
- -12.54%
- YTD
- -17.26%
- 1Y
- -59.94%
- 3Y*
- -63.68%
- 5Y*
- -73.19%
- 10Y*
- -50.77%
- ALL TIME*
- -49.67%
PHIO
- 1D
- -0.49%
- 1M
- 2.50%
- 6M
- 1.49%
- YTD
- -2.38%
- 1Y
- -56.01%
- 3Y*
- -65.10%
- 5Y*
- -64.97%
- 10Y*
- -69.29%
- ALL TIME*
- -65.66%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $238.83K | $503.27K | $408.11K | |
| $208.32K | $1.35M | $578.37K |
GLMD vs. PHIO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GLMD Galmed Pharmaceuticals Ltd. | -17.26% | -76.47% | -41.58% | -93.93% | -72.53% | -41.48% | -46.19% | -15.37% | -25.36% | 160.68% |
PHIO Phio Pharmaceuticals Corp. | -2.38% | -41.67% | -73.68% | -82.97% | -62.80% | -62.83% | -71.40% | -48.17% | -94.07% | -22.21% |
Correlation
The correlation between GLMD and PHIO is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.20 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.17 |
Correlation (All Time) Calculated using the full available price history since Mar 13, 2014 | 0.16 |
Fundamentals
GLMD:
$5.13M
PHIO:
$11.91M
GLMD:
-$1.71
PHIO:
-$1.14
GLMD:
0.26
PHIO:
0.72
GLMD:
$0.00
PHIO:
$0.00
GLMD:
$0.00
PHIO:
-$1.08M
GLMD:
-$8.49M
PHIO:
-$7.23M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GLMD vs. PHIO — Risk / Return Rank
GLMD
PHIO
GLMD vs. PHIO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Galmed Pharmaceuticals Ltd. (GLMD) and Phio Pharmaceuticals Corp. (PHIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GLMD | PHIO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.14 | ||
| Omega ratioGain probability vs. loss probability | 0.90 | 0.88 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | -0.87 | -0.87 | 0.00 |
| Martin ratioReturn relative to average drawdown | -1.25 | -1.22 | -0.03 |
Loading charts...
Drawdowns
GLMD vs. PHIO - Drawdown Comparison
The maximum GLMD drawdown since its inception was -99.99%, roughly equal to the maximum PHIO drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for GLMD and PHIO.
Loading charts...
Drawdown Indicators
| GLMD | PHIO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.99% | -100.00% | +0.01% |
Max Drawdown (1Y)Largest decline over 1 year | -71.21% | -65.45% | -5.76% |
Max Drawdown (3Y)Largest decline over 3 years | -96.89% | -96.34% | -0.55% |
Max Drawdown (5Y)Largest decline over 5 years | -99.92% | -99.66% | -0.26% |
Max Drawdown (10Y)Largest decline over 10 years | -99.99% | -100.00% | +0.01% |
Current DrawdownCurrent decline from peak | -99.98% | -100.00% | +0.02% |
Average DrawdownAverage peak-to-trough decline | -76.28% | -91.71% | +15.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 49.60% | 46.65% | +2.95% |
Volatility
GLMD vs. PHIO - Volatility Comparison
Galmed Pharmaceuticals Ltd. (GLMD) and Phio Pharmaceuticals Corp. (PHIO) have volatilities of 23.75% and 24.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GLMD | PHIO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.75% | 24.55% | -0.80% |
Volatility (6M)Calculated over the trailing 6-month period | 76.21% | 65.78% | +10.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 91.92% | 81.70% | +10.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 166.97% | 183.97% | -17.00% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 138.32% | 150.16% | -11.84% |
Dividends
GLMD vs. PHIO - Dividend Comparison
Neither GLMD nor PHIO has paid dividends to shareholders.
Financials
GLMD vs. PHIO - Financials Comparison
This section allows you to compare key financial metrics between Galmed Pharmaceuticals Ltd. and Phio Pharmaceuticals Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GLMD and PHIO have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
PHIO has higher volatility (24.55%) compared to GLMD (23.75%). In terms of maximum drawdown, GLMD dropped -99.99% vs PHIO's -100.00%.
GLMD currently has the higher Sharpe Ratio (-0.68 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GLMD and PHIO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer